Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

News tagged with 'Nolvadex'

Posted by Chrissie Cole
November 12, 2008 10:37 PM

A new study published in the journal Nature, finds 35 percent of women who take the drug tamoxifen to prevent the return of breast cancer do not respond to the drug -- and scientists think they have figured out why.

Posted by Staff Writer
January 24, 2003 12:00 AM

New research indicates that use of the breast cancer medication tamoxifen, sold under the brand name Nolvadex, may prevent the disease in healthy women. Published in the medical journal The Lancet, the inquiry, conducted by scientists with Cancer Research UK, analyzed data from previous studies using tamoxifen for bre

Posted by Staff Writer
December 02, 2002 12:00 AM

The Canadian health ministry has issued a warning to health care professionals about the possible dangers of using the breast cancer medication tamoxifen. Sold in the United States under the brand name Nolvadex, tamoxifen has been linked to stroke, pulmonary embolism and cancer of the uterus. Although Canadian health

Posted by Staff Writer
November 13, 2002 12:00 AM

Recent studies linking the cancer medication tamoxifen, sold in the United States under the brand name Nolvadex, to the potential risk of venous thromboembolism (pulmonary embolism) has caused Britain's Medicines Control Agency (MCA) to order an investigation of the drug. The MCA's announcement comes after the Interna

Posted by Staff Writer
June 27, 2002 12:00 AM

The U.S. Food and Drug Administration (FDA) and AstraZeneca Pharmaceuticals LP have added a boxed warning and strengthened the WARNINGS section of the label for Tamoxifen Citrate, sold under the brand name Nolvadex. The warning informs healthcare professionals about new risk information of particular relevance to wome

Posted by Staff Writer
July 05, 2001 12:00 AM

Scientists at the Fred Hutchinson Cancer Research Center released a study today that questions the safety of the widely used breast cancer drug tamoxifen. The study, which was published in The Journal of the National Cancer Institute, suggests that women who take tamoxifen and suffer from a reoccurrence of cancer, may

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact InjuryBoard.com

Subscribe

RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes